Thirty years after its quiet introduction, unabated global research interest in IVIG reflects just how much remains unknown about its therapeutic potential.
Attention to meeting payer requirements is good for the bottom line.
As chief operating officer of Protein Sciences, Dr. Mannon Cox has devoted her energy to creating a first-of-its-kind influenza vaccine. Now, she is setting her sights on developing vaccines for other diseases with the company’s innovative technology platform.
While there is no cure for this autoimmune disease, there are many treatments, including behavioral, medicinal and surgical, and research is ongoing.
While all IG products are comparably effective, they also have relevant differences that determine their tolerability by patients.
Until better treatments or a cure can be found, coagulation factor replacement therapies continue to improve the long-term outcome for people with bleeding disorders
Scientific breakthroughs using gene therapy are allowing physicians to take a “precision medicine” approach to treating cancer — with promising results.
Because of a misunderstanding by physicians about the symptoms of celiac disease and how to diagnose it, many believe that only a fraction of individuals with the disease have been diagnosed.
Hospital-acquired infections remain a deadly threat, but the Centers for Disease Control and Prevention in partnership with other healthcare agencies and professionals are working to lower the rates of HAIs with some degree of success.
Anti-aging medicine is a $5 billion industry. Despite its critics, researchers are discovering that interventions designed to turn back time may prove to be more science than fiction.
Exploring the growing need of and up-to-date research for a universal flu vaccine.
